Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School — Houston, Texas

Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School is a clinical research site located in Houston, Texas, United States 77025.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School has participated in 1 clinical trials.

Therapeutic areas: Primary Mitochondrial Myopathy.

Sponsors: Reneo Pharma Ltd.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School?

Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School conducted?

Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School has 1 clinical trials on record. Their work covers Primary Mitochondrial Myopathy.

Is Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School accredited by Crixeo Health?

Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Centre for the Treatment of Pediatric Neurodegenerative Disease, University of Texas McGovern Medical School?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.